Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Doherty

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Journal of Cardiovascular Pharmacology|January 1, 1993
In vitro and in vivo studies with a series of hexapeptide endothelin antagonistsA M Doherty, W L Cody, J X He, et al.
Journal of Medicinal Chemistry|September 3, 1993
Structure-activity relationships of C-terminal endothelin hexapeptide antagonistsA M Doherty, W L Cody, P L DePue, et al.
The Journal of Antibiotics|June 1, 1996
Novel drimane sesquiterpene esters from Aspergillus ustus var. pseudodeflectus with endothelin receptor binding activityM A Hayes, S K Wrigley, I Chetland, et al.
Journal of Medicinal Chemistry|January 17, 1997
Structure-activity relationships of cysteine-lacking pentapeptide derivatives that inhibit ras farnesyltransferaseD M Leonard, K R Shuler, C J Poulter, et al.
Biochemical and Biophysical Research Communications|February 25, 1998
Novel selective quinazoline inhibitors of endothelin converting enzyme-1K Ahn, A M Sisneros, S B Herman, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 1999
The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: part 1W L Cody, C Cai, A M Doherty, et al.
Journal of Medicinal Chemistry|June 23, 1999
Butenolide endothelin antagonists with improved aqueous solubilityW C Patt, X M Cheng, J T Repine, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Potent bicyclic lactam inhibitors of thrombin: Part I: P3 modificationsY St-Denis, C E Augelli-Szafran, B Bachand, et al.
Journal of Medicinal Chemistry|January 6, 1999
Structure-activity relationships for 1-phenylbenzimidazoles as selective ATP site inhibitors of the platelet-derived growth factor receptorB D Palmer, J B Smaill, M Boyd, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 1999
Potent and selective bicyclic lactam inhibitors of thrombin: Part 3: P1' modificationsJ S Plummer, K A Berryman, C Cai, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Journal of Cardiovascular Pharmacology|January 1, 1993
In vitro and in vivo studies with a series of hexapeptide endothelin antagonistsA M Doherty, W L Cody, J X He, et al.
Journal of Medicinal Chemistry|September 3, 1993
Structure-activity relationships of C-terminal endothelin hexapeptide antagonistsA M Doherty, W L Cody, P L DePue, et al.
The Journal of Antibiotics|June 1, 1996
Novel drimane sesquiterpene esters from Aspergillus ustus var. pseudodeflectus with endothelin receptor binding activityM A Hayes, S K Wrigley, I Chetland, et al.
Journal of Medicinal Chemistry|January 17, 1997
Structure-activity relationships of cysteine-lacking pentapeptide derivatives that inhibit ras farnesyltransferaseD M Leonard, K R Shuler, C J Poulter, et al.
Biochemical and Biophysical Research Communications|February 25, 1998
Novel selective quinazoline inhibitors of endothelin converting enzyme-1K Ahn, A M Sisneros, S B Herman, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 1999
The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: part 1W L Cody, C Cai, A M Doherty, et al.
Journal of Medicinal Chemistry|June 23, 1999
Butenolide endothelin antagonists with improved aqueous solubilityW C Patt, X M Cheng, J T Repine, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Potent bicyclic lactam inhibitors of thrombin: Part I: P3 modificationsY St-Denis, C E Augelli-Szafran, B Bachand, et al.
Journal of Medicinal Chemistry|January 6, 1999
Structure-activity relationships for 1-phenylbenzimidazoles as selective ATP site inhibitors of the platelet-derived growth factor receptorB D Palmer, J B Smaill, M Boyd, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 1999
Potent and selective bicyclic lactam inhibitors of thrombin: Part 3: P1' modificationsJ S Plummer, K A Berryman, C Cai, et al.
Pageof 9